发明名称 COMBINATION OF RASAGILINE AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE
摘要 This invention provides a method of treating a patient afflicted with a neurodegenerative disorder, e.g., Huntington's disease, comprising administering to the patient rasagiline as an add-on therapy to or in combination with pridopidine. This invention also provides a package and a pharmaceutical composition comprising rasagiline and pridopidine for treating a patient afflicted with a neurodegenerative disorder. This invention also provides rasagiline for use as an add-on therapy or in combination with pridopidine in treating a patient afflicted with a neurodegenerative disorder. This invention further provides use of rasagiline and pridopidine in the preparation of a combination for treating a patient afflicted with a neurodegenerative disorder.
申请公布号 WO2014052935(A3) 申请公布日期 2014.05.15
申请号 WO2013US62484 申请日期 2013.09.27
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD.;TEVA PHARMACEUTICALS USA, INC.;HAYDEN, MICHAEL;FITZER-ATTAS, CHERYL 发明人 HAYDEN, MICHAEL;FITZER-ATTAS, CHERYL
分类号 A61K31/135;A61K31/445 主分类号 A61K31/135
代理机构 代理人
主权项
地址